Licens Medical to Participate in Korea Derma 2025... Showcasing Precision Cooling Technology 'TargetCool'

Licens Medical (CEO Kim Gunho) announced that it will participate in the international academic conference "Korea Derma 2025," which will be held on October 31 at COEX Magok in Gangseo-gu, Seoul.

Now in its seventh year, Korea Derma is Asia's leading dermatology symposium organized by the Korean Dermatologists Association. It serves as an international academic exchange platform where dermatology and aesthetic medicine experts from around the world share medical knowledge and clinical experience, while showcasing Korea's advanced dermatological medical technologies. At this event, Licens Medical will welcome visitors at booth A37 in the exhibition hall, presenting "TargetCool," a device that features its proprietary precision cooling technology.

TargetCool is a precision cooling medical device that effectively alleviates pain during dermatological procedures through rapid and precise cooling technology. It enables meticulous control of the target temperature during procedures, ensuring stable pain relief across various clinical settings, thereby enhancing both the efficiency of medical professionals and patient satisfaction. In particular, Licens Medical's precision cooling technology is recognized for minimizing patient discomfort and providing a more comfortable treatment experience. The company expects this event to confirm strong interest and demand from dermatologists both in Korea and abroad.

A representative from Licens Medical stated, "We expect that participating in Korea Derma 2025 will provide an opportunity to share the precision cooling technology and diverse insights of TargetCool, developed by Licens Medical, with medical professionals." The representative added, "TargetCool is already recognized for its technological excellence and is being actively used in various clinical fields. We will continue to strengthen our position as a global innovative medical company."